Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-06

Clinical Trial Update: Lifestyle Intervention for Type 2 Diabetes in Primary Care (CREDOenAP) [NA]

View source ↗

Summary

This entry describes a planned lifestyle intervention trial for Type 2 Diabetes Mellitus in primary care (CREDOenAP). The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Parc Sanitari Pere Virgili | Conditions: Type 2 Diabetes Mellitus (T2DM) | NA | Status: NOT_YET_RECRUITING